Fatal familial insomnia: Reporting a case of the rare nightmare
E Hogue1, D Weinberg2, E Palecek2
1College of Medicine, Medical University of South Carolina, Charleston SC, USA.
Abstract:
Prion diseases are rare, incurable, and rapidly progressive. Pathogenic misfolded proteins accumulate in the central nervous system causing fatal neurodegeneration. Fatal familial insomnia (FFI) is an even rarer, hereditary subset of prion disease. The initial clinical course is nonspecific, leading to difficulties with diagnosis. We describe a patient with a family history of prion disease who presented with early symptoms of FFI including disordered sleep, cognitive dysfunction, and autonomic dysregulation. Notably, diagnostic studies including magnetic resonance imaging (MRI), cerebrospinal fluid (CSF) analysis, and electroencephalography (EEG) did not show changes characteristic of prion disease. However, genetic testing showed a pathological, heterozygous mutation c.532G> A (p.Asp178Asn), confirming FFI. His clinical course progressed rapidly, and death occurred several months after the initial hospital presentation. We discuss the pathophysiology and diagnosis of FFI and the emotional care required to treat this fatal disease. General practitioners should be aware of this rare diagnosis to improve patient management.
Insights
Fatal familial insomnia (FFI) is a rare, inherited prion disease. Genetic testing is crucial for diagnosis, as standard tests may be inconclusive for this fatal neurodegenerative condition.
Area of Science:
- Neurology
- Genetics
- Pathology
Background:
- Prion diseases are fatal neurodegenerative disorders caused by misfolded proteins.
- Fatal familial insomnia (FFI) is a rare, hereditary prion disease with nonspecific early symptoms.
- Early diagnosis of FFI is challenging due to the lack of characteristic findings in initial standard diagnostic tests.
Observation:
- A patient with a family history of prion disease presented with early FFI symptoms: sleep disturbances, cognitive decline, and autonomic dysfunction.
- Standard diagnostic investigations, including MRI, CSF analysis, and EEG, were unremarkable for prion disease.
- Genetic testing revealed a pathogenic mutation (c.532G>A or p.Asp178Asn), confirming the FFI diagnosis.
Findings:
- Genetic analysis is essential for diagnosing FFI, especially when conventional methods are negative.
- The identified mutation c.532G>A (p.Asp178Asn) confirms the hereditary nature of FFI in this patient.
- The patient experienced rapid disease progression and mortality within months of initial presentation.
Implications:
- Increased awareness among general practitioners is vital for timely FFI diagnosis and improved patient management.
- Understanding FFI pathophysiology aids in developing diagnostic and therapeutic strategies for prion diseases.
- Addressing the emotional and psychological needs of patients and families is critical in managing this devastating illness.
Related Concept Videos
Insomnia
Multiple factors contribute...
Narcolepsy
Management of Insomnia
REM Sleep Behavior Disorder
RBD is significantly associated with...
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:


